Skip to content

The Effect of Facial Candling on Inflammatory Mediators and Pain in Allergic Rhinitis Patients:A randomized controlled trial

The Effect of Facial Candling on Inflammatory Mediators and Pain in Allergic Rhinitis Patients:A randomized controlled trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000299404
Enrollment
66
Registered
2016-03-07
Start date
2016-04-01
Completion date
2016-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Treatment of facial candling has been very popular especially in Malaysia. It is believed that traditional treatment helps in relieving allergic rhinitis. There is, however, a lack of scientific evidence to support the practice of traditional treatment and the mechanism as to how facial candling treatment reduce allergic rhinitis. The aim of this study is to investigate the immediate effect of facial candling, substance P, inflammatory mediators among allergic rhinitis patients.

Interventions

The patients Allergic rhinitis in group (Group A) will be treated by one certified practitioner of traditional facial candling, with the treatment being applied within 15 minutes in one session. The practitioner will pass the smoke release from facial candle around the patients face. The white like powder appears on the patients face will be clean with water.

Sponsors

Dr. Long Chiau Ming
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1.Age between 18- 65 years old 2.Participant had a positive skin prick test to at least one of : -seafood; or -house dust mite; or -animal dander; or -pollen 3.Pass urine pregnancy test for female. 4.Willing to participate in this study

Exclusion criteria

1.Pregnant woman 2.Asthma and Chronic obstructive pulmonary disease (COPD) patients 3.Patients who taking pain killer pills, received antihistamine drug and steroid

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 9, 2026